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Abstract Wegener’s granulomatosis (WG) frequently
involves the subglottis and trachea and may compromise
the upper airway. The objective of this study is to evaluate
retrospectively the eVect of treatment of subglottic stenosis
(SGS) and tracheal stenosis (TS) by dilatation tracheoscopy
(DT) in patients with WG. We performed a cohort study on
all patients who underwent DT between February 2001 and
September 2005 in our institution. From this cohort we
identiWed a total of nine WG patients. In all patients, clini-
cal, serological and histopathological data had been pro-
spectively collected by a standardized protocol from the
time point of diagnosis. In the nine patients that were iden-
tiWed with SGS or TS due to WG (eight women and one
man), a total of 22 DT’s were performed. Two patients
needed a tracheostoma (one temporarily). The mean fol-
low-up after the Wrst DT was 25.4 § 14.1 months. Two
patients did not experience a recurrence of SGS or TS. Six
patients required a second DT without recurrence of local
disease. The remaining patient underwent 8 DT's in a
4-year period. DT can oVer a simple and repeatable solu-
tion to SGS and TS due to WG. Seven of the nine patients
required more than one dilatation and some patients experi-
ence a functional restriction. One patient has a deWnitive
tracheostoma.
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Introduction
Wegener’s granulomatosis (WG), Wrst described by Fried-
rich Wegener in Stuttgart in 1936, is multi-system disease
characterized by a necrotizing granulomatous arteritis of
the upper and lower respiratory tract and a necrotizing
crescentic glomerulonephritis [1]. Vasculitis may also
aVect other organs such as the eyes, skin, joints, heart and
the nervous system [1]. Upper respiratory tract manifesta-
tions—particularly sinusitis, ulcerations of the nasal
mucosa and epistaxis—are common and debilitating pre-
sentations. Subglottic stenosis (SGS) and tracheal stenosis
(TS), however, are potentially life threatening presentations
of WG. SGS has been found to occur in approximately
16–23% in patients carrying a diagnosis of WG [2, 3]. This
narrowing of the upper airway at the level of cricoid carti-
lage and/or upper tracheal rings presents a management
dilemma. Dilatation tracheoscopy (DT) is one of the possi-
ble options for treatment of SGS and TS. The long-term
eVects of DT in patients with WG have never been
reported.
DT is a minimally invasive self-standing procedure. It
can be used for elective and emergency intervention in
patients with subglottic and tracheal stenosis. This has been
described elsewhere (G.B. Halmos, F.G. Dikkers, Dilata-
tion tracheoscopy in treatment of subglottic and tracheal
stenosis, submitted for publication). Patients suVering from
WG present diVerences (age, sex, response to treatment)
compared to other aetiologies, which justiWes separate pub-
lication. The objective of this study is therefore to evaluate
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the eVect of the treatment of SGS and TS by DT in patients
with WG.
Methods
We retrospectively identiWed all patients from our institu-
tion that underwent a DT between February 2001 and Sep-
tember 2005. The total cohort of benign, grade II (Myer-
Cotton) subglottic or tracheal stenosis consisted of patients
with a history of posttraumatic tracheal stenosis, thermal
tracheal stenosis, posttracheotomy cicatricial stenosis, tra-
cheal rupture, postintubation stenosis, and WG, amongst
others. As stated before, the cohort is described elsewhere.
From the cohort we identiWed a total of nine WG
patients. These nine patients had been diagnosed with WG
between May 1990 and August 2003. During this period a
total of 195 patients in our institution were diagnosed as
having WG (including the nine patients who underwent
DT). From this cohort, one additional patient underwent a
DT for SGS in 1992. Three other patients were diagnosed
with relatively mild SGS or TS that did not necessitate DT.
The reference group for the comparison of demographic
and serological data consisted of the total cohort, minus the
patients who underwent DT and minus the three patients
with mild tracheal stenosis who did not undergo DT. DiVer-
ences in age between the DT group and the reference group
were tested with the Mann Whitney U test; diVerences in
the male/female ratio and antineutrophil cytoplasmatic
autoantibodies (ANCA) speciWcity were tested with chi-
square test. Although this was a retrospective study, the
clinical, serological and histopathological data of both the
DT group and the control group had been prospectively col-
lected by a standardised protocol starting at the time of the
diagnosis of Wegener’s granulomatosis. Extrarenal organ
involvement was categorized as described previously [4].
ANCA was assayed with indirect immunoXuorescence.
Sera from all patients were assayed for the presence of anti-
bodies against proteinase 3 (PR3–ANCA), myeloperoxidase
(MPO–ANCA) and elastase as described previously [5].
DT was performed when patients complained of pro-
gressive dyspnoea in combination with decrease of peak
Xows. DT is an endoscopically performed intervention. An
intubation laryngoscope, a Groningen optical dilatation tra-
cheoscope (Karl Storz 1033R) (Fig. 1), telescope and suc-
tion tubes are required for this procedure. The tracheoscope
has a length of 30 cm. The proximal end of the tracheo-
scope is designed in such a way that customary ventilation
tubes and a 30 cm Hopkins® straight forward telescope
(Karl Storz 27005AA) can be connected. The distal end of
the instrument contains numerous lateral tiny openings,
which enable air to come through in the centre of the steno-
sis. The dilatation tracheoscope is available with a diameter
of 8 and 12 mm. The appropriate size of the instrument is
determined by the size of the patient’s larynx and the
healthy portion of the trachea.
The intervention is carried out under general anaesthe-
sia. Following the administration of the anaesthesia, with
ventilation taking place via an anaesthesia mask, the dilata-
tion tracheoscope is introduced under endoscopic control.
The stenosis is then visible through the vocal cords (Fig. 2).
The bevelled design of the tip, which can be advanced for-
ward through the stenosis, ensures that the ventilation is
maintained during the process. The conical construction of
the tip enables the instrument to be advanced up to the
wider section of the tracheoscope (Fig. 3), after which the
tracheoscope remains in place for 5 to 10 min.
The constellation of the tracheoscope is suitable for most
grade II (Myer-Cotton) subglottic or tracheal stenosis. The
intervention can be repeated after any time interval.
Fig. 1 Groningen dilatation tracheoscopeEur Arch Otorhinolaryngol (2008) 265:549–555  551
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Typically, no antibiotics or corticosteroids are used. The
use of mitomycin-C was considered in each case, but it was
never used, because mitomycin-C should be used in fresh
wounds. Patients are dismissed the day after DT. PeakXows
were measured three times (Respironics Healthscan Inc.,
Cedar Groove, NJ, USA) in an upright position. The mean
of the three measurements was taken.
Results
Patients
The total cohort of patients who underwent DT because of
SGS and TS was 25. Nine of them were identiWed as
patients with WG. Eight were female, one was male. The
other 16 patients did not have vasculitis as cause of their
stenosis. The causes in these 16 patients were posttraumatic
[5], postintubation [4], idiopathic [4], post tracheotomy [2]
and post thermal [1] injury. The mean age of the patient
group at Wrst presentation of WG was 41.6 § 11.2 years
(Table 1). The interval between the presentation of WG and
the Wrst symptoms of laryngeal and tracheal stenosis varied
between 0 and 122 months (mean 48.9 § 44.1). The aver-
age age at of the time of presentation of the stenosis was
45.6 § 11.9 years (Table 1).
At diagnosis, all WG patients had additional organ
involvement outside the otorhinolaryngologic area. The
kidneys, lungs and eyes were aVected three times. The
joints were aVected two times. The skin was aVected once
(Table 1).
As shown in Table 1, the number of relapses of WG var-
ied between 0 and 12. There was no relation between the
number of relapses and the occurrence of TS or SGS. In
only one of the DT procedures there was endoscopic and/or
histopathological evidence of vasculitis activity. The TS or
SGS occurred in 95% in periods where the disease
appeared to be less active.
In Table 2 the patient characteristics of the 9 patients
who underwent DT for SGS or TS are compared with those
patients who were diagnosed with WG in the same time
frame but who did not have evidence of SGS or TS. In the
DT group, 89% were female whereas 43% of patients in the
reference group were female (P < 0.01). In the DT group
the age at diagnosis of WG was signiWcantly lower in com-
parison with the reference group (P <0 . 0 5 ) .
Follow-up of the DT-group
In the nine patients identiWed with SGS or TS due to WG, a
total of 22 DT’s were performed (Table 3). The mean fol-
low-up after treatment was 25.4 § 14.1 months (Table 3).
Two patients (numbers 7 and 8) did not experience a recur-
rence of signiWcant stenosis. Six patients (numbers 1, 2, 3,
4, 6, 9) required a second DT without recurrence of local
disease activity after the second DT. One of these patients
(patient number 6) had acute WG in the trachea, proven by
biopsy (Fig. 4). She was treated with high dose predniso-
lone (intravenous methylprednisolone 1000 mg on three
consecutive days) and intubation for a week. She could be
detubated a week later (Fig. 5). Two patients needed a tra-
cheostoma (patient numbers 2 and 5). One patient (number
Fig. 2 Patient nr 9 pre dilatation. During laryngotracheoscopy a
subglottic stenosis is clearly visible. The vocal cords can be seen bilat-
erally
Fig. 3 Patient nr 9 during DT. The dilatation tracheoscope is intro-
duced through the stenosis. Parts of the tissue protrude through the tiny
distal openings of the tracheoscope552 Eur Arch Otorhinolaryngol (2008) 265:549–555
123
5) developed a cricoid stenosis 5 years after the diagnosis
of WG. Initially the stenosis was treated with two DT’s.
During a pregnancy the patient required an emergency tra-
cheotomy because of a threatened airway. After pregnancy
she was treated with a CO2 laser and three DT’s. Unfortu-
nately, however, she required a deWnitive tracheostomy.
Currently the process of decannulation is taking place. One
patient (number 2) became respiratory insuYcient at diag-
nosis of WG and had a tracheotomy for 3 months. She sub-
sequently developed a cicatricial SGS, but she has enough
lumen to live without a tracheostomy (Table 3).
The eVect of DT on peakXows was evaluated in Wve
patients. In these patients the mean (§SD) peakXow
increased from 164 § 45.7 l/min before DT to 226 § 69.6 l/
min after dilatation. An example of the eVect of DT on the
peakXow is shown in Fig. 6. Two months after this patient
had been diagnosed with WG she developed complaints of
dyspnoea. Tracheoscopy revealed a SGS with signs of
active vasculitis. After treatment with high-dose corticoste-
roids she had a regression of the WG activity. Fourteen and
28 months after Wrst diagnosis of SGS a dilatation tracheos-
copy was performed successfully.
Discussion
There are multiple causes of benign laryngeal or tracheal
stenosis, the most common being traumatic. However, if
there is no prior history of tracheal trauma, the aetiology of
the stenosis may be obscure and diYcult to determine,
necessitating a systematic approach to make the diagnosis.
Excluding trauma, the diVerential diagnosis of TS can be
subdivided into four categories: congenital, neoplastic,
infectious, and inXammatory.
Table 1 Patient characteristics of nine patients with Wegener’s Granulomatosis (WG) and subglottic stenosis (SGS) or tracheal stenosis (TS).
Clinical and laboratory Wndings. ANCA antineutrophil cytoplasmatic autoantibodies, PR3 proteinase 3, MPO myeloperoxidase
Patient 
No.
Sex Age at
presentation
of WG
Organs
involved
at Wrst 
presentation
of WG
ANCA
speciWcity
Number of
relapses
of WG
Organs involved at 
Wrst relapse of WG
Follow-up 
after diagnosis
of WG (years)
Age at Wrst 
presentation
of SGS or TS
Interval 
between
diagnosis 
of WG and
Wrst treatment
of TS or SGS
(months)
1 M 44 Joints PR3 12 Joints, skin 17 51 92
2 F 26 Lungs, Trachea PR3 1 Lungs, kidney 14 26 0
3 F 43 Trachea MPO 1 Lungs 12 43 0
4 F 57 Joints PR3 2 Ear, eye, kidney, joints 12 67 122
5 F 26 Trachea PR3 1 Kidney, eye 11 31 60
6 F 51 Mastoid PR3 2 Nose (concha inferior), 
mastoid
10 58 81
7 F 42 Ear drum Atypical 0 Lung, ear drum 8 45 35
8 F 52 Nose PR3 1 Nose (septum and concha), 
joints, eye
75 6 4 8
9 F 33 Nasal vessels PR3 0 Vessels 4 33 2
Table 2 Patient characteristics of nine patients with Wegener’s granulomatosis who underwent DT for SGS or TS compared with the reference
group of 182 patients who were diagnosed with WG in the same period without evidence of SGS or TS
WG Wegener's granulomatosis, DT dilatation tracheoscopy, SGS subglottic stenosis, TS tracheal stenosis, ANCA antineutrophil cytoplasmatic auto-
antibodies, PR3 proteinase 3, MPO myeloperoxidase, HNE human neutrophil elastase
WG patients who 
underwent DT (n =9 )
WG patients without evidence 
of SGS or TS (n = 182)
P value
Male/ female number (%) 1/8 (11%/89%) 104/78 (57%/43%) <0.01
Age at diagnosis of WG 
(years, mean § SD)
41.6 § 11.2 53.3 § 17.0 <0.05
ANCA speciWcity PR3-ANCA: n =8  ( 8 9 % )
MPO-ANCA: n = 1 (11%)
PR3-ANCA: n = 160 (88%)
MPO-ANCA: n = 13 (7.1%)
HNE-ANCA: n =1  ( 0 . 5 % )
ANCA-negative: n = 8 (4.4%)
Not signiWcantEur Arch Otorhinolaryngol (2008) 265:549–555  553
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Congenital TS is really quite rare and is often the result
of posterior fusion of the tracheal rings, thereby forming
complete rings. Other causes of congenital stenosis include
vascular rings and other congenital cardiovascular anoma-
lies such as an anomalous subclavian artery. These patients
typically present at young age.
Primary benign tumours of the trachea such as chondro-
mas,  Wbromas, squamous papillomas, hemangiomas, and
granular cell tumours are also unusual causes of stenosis. In
addition, extrinsic compression of the trachea can occur by
thyroid neoplasms and goiters.
A number of infections of the bronchopulmonary tree
can lead to TS. Fungal infections such as histoplasmosis
and blastomycosis should always be considered when the
aetiology of the stenosis is unclear. Serologic testing and
histopathologic examination can be helpful in this regard.
Other infectious causes of TS include rhinoscleroma, tuber-
culosis, syphilis, and diphtheria.
Non-infectious, inXammatory causes of TS include scle-
rosing mediastinitis, primary amyloidosis, and sarcoidosis.
WG and relapsing polychondritis can also cause TS, but
they are almost always seen in combination with other,
more classic hallmarks of these diseases.
A laryngeal or tracheal stenosis is optimally diagnosed via
tracheal visualization, which is generally performed by an
otorhinolaryngologist. Indirect and Wberoptic laryngoscopy
are non-invasive examination techniques that can be per-
formed in the oYce, but usually do not show the entire
trachea. A subglottic stenosis is not always visible, there-
fore direct rigid tracheoscopy in general anaesthesia is
indicated in cases suspect of WG.
Recurrent SGS is a well recognized but uncommon fea-
ture of WG. Patients with WG who develop laryngotracheal
disease have usually already been diagnosed as such
because of the presence of disease in other organs at the
same time or at a previous occasion [6]. Isolated involve-
Fig. 4 Patient nr 6 with acute WG during biopsy of a subglottic steno-
sis
Table 3 Follow-up after last 
DT
Patient 
number
Location 
of stenosis
Number 
of DT’s
Follow-up after last 
treatment (months)
Tracheotomy 
required
1 Subglottic 2 19 No
2 Subglottic 2 21 Yes, temporary
3 Trachea 2 43 No
4 Trachea 2 14 No
5C r i c o i d 8 1 2 Y e s
6 Subglottic 2 16 No
7 Subglottic 1 54 No
8 Subglottic 1 26 No
9 Subglottic 2 24 No
Fig. 5 Patient nr 6 after pulse therapy and intubation. The picture was
taken one week after Fig. 4554 Eur Arch Otorhinolaryngol (2008) 265:549–555
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ment of the subglottic larynx is conspicuously rare—only a
few cases have been reported in the literature [2, 7, 8]. In
our series, however, three patients had SGS or TS as pre-
senting symptom of their WG. We do not have an explana-
tion for this rare presentation.
Another particular Wnding is that eight of our nine
patients were female. This contrasts signiWcantly with the
male/female ratio in the reference group that consisted of
WG patients that were diagnosed in the same period as the
DT group but who did not have evidence of SGS or TS. It is
diYcult to speculate on the reason for this female prepon-
derance. Anatomically the female airway is narrower than
the male, making it more prone for post-intubation stenosis.
However, we even had females presenting with a SGS or
TS. More research in larger series has to be performed to
explain this phenomenon.
In cases where the diagnosis of WG is suspected, ANCA
testing should be part of the routine laboratory evaluation
[9]. C-ANCA has been shown to be a speciWc marker for
WG with rare false-positive results; p-ANCA testing is
much less speciWc. Only the particular laboratory Wndings
of c-ANCA reacting with PR3 and p-ANCA reacting with
myeloperoxidase (MPO) are speciWc for the autoimmune
vasculitides [9, 10]. Notably, seven of our nine patients that
underwent DT were PR3-ANCA positive and one patient
was MPO-ANCA positive.
All patients had involvement of additional organs. In
three patients the disease presented as a stenosis, and
laryngotracheoscopy revealed the size and site of the
lesion. Organs involved showed no pattern in which there
should be additional suspicion for the development of SGS
or TS. There was no relation between the number of
relapses and the development of TS or SGS. The TS or
SGS occurred more often in periods where the disease
appeared to be less active.
Remarkably, TS or SGS predominantly became manifest
in periods in which WG appeared to be inactive. Interest-
ingly, seven out of our nine patients who developed TS or
SGS had not been diagnosed previously with tracheal
involvement of WG, neither at Wrst presentation nor at
relapse(s). We speculate that during active disease a subclin-
ical tracheal involvement occurs which may subsequently
heal with scar formation. To examine this hypothesis in
patients, elective tracheoscopy should be performed in all
patients with WG. The time interval between presentation of
clinical stenosis in these seven patients (mean 63 months,
median 60, range 2–122) favours watchful waiting.
DT with the Groningen dilatation tracheoscope is a safe,
minimally invasive procedure for the treatment of Cotton-
Myer grade II subglottic or tracheal stenosis of various ori-
gin. It is an elegant, self-standing surgical intervention,
where no additional interventions are needed. For an over-
view of the eVect of DT the reader is referred elsewhere
(G.B. Halmos, F.G. Dikkers, Dilatation tracheoscopy in
treatment of subglottic and tracheal stenosis, submitted for
publication).
Nowadays, mitomycin-C, an alkylating agent that inhib-
its cell division, protein synthesis, and Wbroblast prolifera-
tion [11], is increasingly used as adjuvant treatment in the
management of selected cases of laryngeal and tracheal ste-
nosis, for example luminal obstruction in fresh circular
sutured wounds. However, the laryngeal and tracheal ste-
noses of WG patients are almost always of older age and
display advanced scarring at the time of diagnosis. Dilating
such “mature” stenoses will inevitably lead to damage of
tracheal epithelium. However, this damage is considerably
diVerent from granulomatous scariWcation in sutured
lumina and, therefore, we do not expect an additional
favourable response to mitomycin. Therefore, we have not
applied mitomycin-C in our WG patient cohort.
In cases where TS or SGS develops, there is always the
question whether or not to intervene, and the question of
timing of the intervention. There are two main parameters
in these patients: complaints, and physical signs. One might
see this as a two-by-two table, with complaints on the x-axis,
and peakXow values on the y-axis. Progressive complaints
and progressive decline of peakXow values (+/+) indicate
intervention by DT. Absence of progressive complaints and
unchanged peakXow values (¡/¡) indicate watchful wait-
ing. Absence of progressive complaints with decline of
peakXow values (¡/+) need to be addressed when the
values reach a critical level, in which it can be expected that
a common cold might lead to severe stenosis of the air-
ways. Finally, progressive complaints with unchanged
peakXow values (+/¡) indicate that pulmonary function
tests should be performed, and, if negative, indicate that the
patient has an incorrect perception of his physical poten-
tials. This can then be addressed. Unfortunately, in only
Wve of the nine patients in this retrospective study, we have
peak Xow measurements. A reason is that two patients have
or had a tracheostomy.
Fig. 6 Peak Xow measurements after dilatation of patient number 9.
The arrows indicate the DT procedures
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We have registered no complications or deaths during or
because of DT. We have three reasons to regard dilatation
tracheoscopy as a minimally invasive intervention. We
have experienced no complications related to dilatation tra-
cheoscopy. It requires short hospitalization (generally
3 days). The intervention is not straining for the patients.
A variety of surgical techniques has been used to treat
SGS or TS of other aetiologies [12, 13]. The success of
these surgical techniques in upper airway stenosis related to
WG has been variable [3, 14]. In our series two out of nine
patients were treated once for upper airway stenosis with
dilatation without any re-stenosis because of WG.
Unfortunately, two patients required a tracheostomy.
One was temporary, but one patient needed a permanent
tracheotomy (11%): this was the pregnant woman needing
an emergency procedure. This number equals that of Gluth
et al. [9].
Conclusion
WG as such is a rare disease, and SGS and TS are rare
symptoms in patients with WG. DT can oVer a simple and
repeatable solution to this very serious symptom. Patient
complaints and monitoring of peakXow values oVer simple
tools for the decision whether or not to intervene. However,
a causative solution to WG should be the ultimate goal.
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